BRKR
Price
$77.33
Change
-$1.23 (-1.57%)
Updated
Apr 19, 1:58 PM EST
13 days until earnings call
LAB
Price
$2.52
Change
-$0.02 (-0.79%)
Updated
Apr 19, 6:59 PM EST
13 days until earnings call
Ad is loading...

Analysis and predictions BRKR vs LAB

Header iconBRKR vs LAB Comparison
Open Charts BRKR vs LABBanner chart's image
Bruker
Price$77.33
Change-$1.23 (-1.57%)
Volume$400
CapitalizationN/A
Standard BioTools
Price$2.52
Change-$0.02 (-0.79%)
Volume$1.22M
CapitalizationN/A
View a ticker or compare two or three
BRKR vs LAB Comparison Chart

Loading...

BRKRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BRKR vs. LAB commentary
Apr 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRKR is a Hold and LAB is a Hold.

COMPARISON
Comparison
Apr 20, 2024
Stock price -- (BRKR: $78.56 vs. LAB: $2.54)
Brand notoriety: BRKR and LAB are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BRKR: 267% vs. LAB: 124%
Market capitalization -- BRKR: $12.93B vs. LAB: $1.04B
BRKR [@Medical Specialties] is valued at $12.93B. LAB’s [@Medical Specialties] market capitalization is $1.04B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRKR’s FA Score shows that 2 FA rating(s) are green whileLAB’s FA Score has 0 green FA rating(s).

  • BRKR’s FA Score: 2 green, 3 red.
  • LAB’s FA Score: 0 green, 5 red.
According to our system of comparison, BRKR is a better buy in the long-term than LAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRKR’s TA Score shows that 5 TA indicator(s) are bullish while LAB’s TA Score has 3 bullish TA indicator(s).

  • BRKR’s TA Score: 5 bullish, 5 bearish.
  • LAB’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BRKR is a better buy in the short-term than LAB.

Price Growth

BRKR (@Medical Specialties) experienced а -12.98% price change this week, while LAB (@Medical Specialties) price change was -12.71% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.24%. For the same industry, the average monthly price growth was -4.56%, and the average quarterly price growth was +9.29%.

Reported Earning Dates

BRKR is expected to report earnings on Aug 01, 2024.

LAB is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Medical Specialties (-2.24% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for BRKR with price predictions.
OPEN
A.I.dvisor published
a Summary for LAB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BRKR($12.9B) has a higher market cap than LAB($1.04B). LAB YTD gains are higher at: 14.932 vs. BRKR (6.975). BRKR has higher annual earnings (EBITDA): 676M vs. LAB (-54.46M). BRKR has more cash in the bank: 488M vs. LAB (115M). LAB has less debt than BRKR: LAB (98.2M) vs BRKR (1.38B). BRKR has higher revenues than LAB: BRKR (2.96B) vs LAB (106M).
BRKRLABBRKR / LAB
Capitalization12.9B1.04B1,245%
EBITDA676M-54.46M-1,241%
Gain YTD6.97514.93247%
P/E Ratio32.04N/A-
Revenue2.96B106M2,796%
Total Cash488M115M424%
Total Debt1.38B98.2M1,405%
FUNDAMENTALS RATINGS
BRKR vs LAB: Fundamental Ratings
BRKR
LAB
OUTLOOK RATING
1..100
5168
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
29100
SMR RATING
1..100
28100
PRICE GROWTH RATING
1..100
4743
P/E GROWTH RATING
1..100
85100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LAB's Valuation (50) in the Medical Specialties industry is in the same range as BRKR (57). This means that LAB’s stock grew similarly to BRKR’s over the last 12 months.

BRKR's Profit vs Risk Rating (29) in the Medical Specialties industry is significantly better than the same rating for LAB (100). This means that BRKR’s stock grew significantly faster than LAB’s over the last 12 months.

BRKR's SMR Rating (28) in the Medical Specialties industry is significantly better than the same rating for LAB (100). This means that BRKR’s stock grew significantly faster than LAB’s over the last 12 months.

LAB's Price Growth Rating (43) in the Medical Specialties industry is in the same range as BRKR (47). This means that LAB’s stock grew similarly to BRKR’s over the last 12 months.

BRKR's P/E Growth Rating (85) in the Medical Specialties industry is in the same range as LAB (100). This means that BRKR’s stock grew similarly to LAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BRKRLAB
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 23 days ago
70%
Bullish Trend 23 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
BRKRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIDRX9.840.03
+0.31%
Hartford Schroders Intl Multi-Cp Val SDR
BMIIX7.45N/A
N/A
BNY Mellon Income Stock I
PCMRX22.51-0.02
-0.09%
Pioneer Mid Cap Value R
TQGEX16.56-0.03
-0.18%
T. Rowe Price Integrated Global Eq
LSGRX24.72-0.15
-0.60%
Loomis Sayles Growth Y

BRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRKR has been loosely correlated with A. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if BRKR jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRKR
1D Price
Change %
BRKR100%
-5.28%
A - BRKR
63%
Loosely correlated
-1.57%
WAT - BRKR
61%
Loosely correlated
-3.27%
MTD - BRKR
55%
Loosely correlated
-0.46%
CRL - BRKR
52%
Loosely correlated
-1.10%
TMO - BRKR
51%
Loosely correlated
-1.05%
More